Chemokine-mucin fusions linked to glycosylphosphatidylinositol (GPI)-anchors in tissue regeneration and as tumour immune adjuvants

Details for Australian Patent Application No. 2006319440 (hide)

Owner Apceth GmbH & Co KG

Inventors Grone, Hermann-Josef; Nelson, Peter; Huss, Ralf

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006319440

PCT Pub. Number WO2007/062844

Priority 05026397.9 02.12.05 EP

Filing date 30 November 2006

Wipo publication date 7 June 2007

Acceptance publication date 9 February 2012

International Classifications

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/062844 Priority application(s): WO2007/062844

2 April 2009 Assignment before Grant

  Nelson, Peter The application has been assigned to Apceth GmbH & Co KG

9 February 2012 Application Accepted

  Published as AU-B-2006319440

7 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006319462-Oxadiazole derivatives with CRTH2 receptor activity

2006319439-Atmospheric density reference control